Following positive trial results, retatrutide, a novel peptide option for managing adult-onset metabolic disorder, has obtained regulatory approval from Great Britain's Medicines and Regulatory Agency ( https://myaigve414187.blog5star.com/41604495/retatrutide-medication-peptide-british-green-light-and-launch